Purpose <p>Hypoparathyroidism (HypoPT) is one of the most common complications of surgical treatment for thyroid cancer and afflicated patients often report symptoms or impairments in quality of life (QoL). We aimed to investigate differences in various QoL domains between thyroid cancer survivors with and without permanent hypoparathyroidism.</p> Methods <p>Thyroid cancer survivors with a minimum of 1.5 years post-diagnosis completed the EORTC core questionnaire (EORTC QLQ-C30) and the EORTC thyroid module (QLQ-THY34). Sociodemographic and clinical information were obtained from the patients themselves and their medical charts. Analysis of covariance was used to compare QoL between survivors with and without hypoparathyroidism (adjusting for age, gender, time since diagnosis, and comorbidity).</p> Results <p>Of the 126 participants, 21 (17%) were diagnosed with permanent HypoPT. There was no evidence of differences regarding any QoL domain between survivors due to hypoparathyroidism. The symptoms with the highest burden for both groups were <i>fatigue</i> (hypoPT: 24.9; non-hypoPT: 32.8; <i>p</i> = 0.151) and <i>insomnia</i> (hypoPT: 22.2; non-hypoPT: 30.8; <i>p</i> = 0.213). Thyroid cancer specific impairments were observed for <i>joint pain</i> (hypoPT: 28.6; non-hypoPT: 34.0; <i>p</i> = 0.480), <i>worry about important others</i> (hypoPT: 25.8; non-hypoPT: 27.9; <i>p</i> = 0.765), <i>exhaustion</i> (hypoPT: 23.8; non-hypoPT: 27.9; <i>p</i> = 0.482), and <i>lacking social support</i> (hypoPT: 36.5; no-hypoPT: 23.0; <i>p</i> = 0.070).</p> Conclusion <p>The present study appears to show that QoL in thyroid cancer survivors may be unrelated to hypoparathyroidism, further suggesting a more complex relationship between these two aspects.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Quality of life in thyroid cancer survivors with and without permanent hypoparathyroidism

  • Matthias Büttner,
  • Gerasimos Sykiotis,
  • Akram Al-Ibraheem,
  • Monica Pinto,
  • Ioannis Iakovou,
  • Arild Andre Østhus,
  • Eva Hammerlid,
  • Laura Deborah Locati,
  • Eva Maria Gamper,
  • Juan Ignacio Arraras,
  • Susan J. Jordan,
  • Naomi Kiyota,
  • Deborah Engesser,
  • Katherine Taylor,
  • Rita Canotilho,
  • Georgios Ioannidis,
  • Olga Husson,
  • Ricardo Ribeiro Gama,
  • Giuseppe Fanetti,
  • Laura Moss,
  • Johanna Inhestern,
  • Guy Andry,
  • Harald Rimmele,
  • Susanne Singer

摘要

Purpose

Hypoparathyroidism (HypoPT) is one of the most common complications of surgical treatment for thyroid cancer and afflicated patients often report symptoms or impairments in quality of life (QoL). We aimed to investigate differences in various QoL domains between thyroid cancer survivors with and without permanent hypoparathyroidism.

Methods

Thyroid cancer survivors with a minimum of 1.5 years post-diagnosis completed the EORTC core questionnaire (EORTC QLQ-C30) and the EORTC thyroid module (QLQ-THY34). Sociodemographic and clinical information were obtained from the patients themselves and their medical charts. Analysis of covariance was used to compare QoL between survivors with and without hypoparathyroidism (adjusting for age, gender, time since diagnosis, and comorbidity).

Results

Of the 126 participants, 21 (17%) were diagnosed with permanent HypoPT. There was no evidence of differences regarding any QoL domain between survivors due to hypoparathyroidism. The symptoms with the highest burden for both groups were fatigue (hypoPT: 24.9; non-hypoPT: 32.8; p = 0.151) and insomnia (hypoPT: 22.2; non-hypoPT: 30.8; p = 0.213). Thyroid cancer specific impairments were observed for joint pain (hypoPT: 28.6; non-hypoPT: 34.0; p = 0.480), worry about important others (hypoPT: 25.8; non-hypoPT: 27.9; p = 0.765), exhaustion (hypoPT: 23.8; non-hypoPT: 27.9; p = 0.482), and lacking social support (hypoPT: 36.5; no-hypoPT: 23.0; p = 0.070).

Conclusion

The present study appears to show that QoL in thyroid cancer survivors may be unrelated to hypoparathyroidism, further suggesting a more complex relationship between these two aspects.